Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / COM
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
801
-
Shares change
-
-181K
-
Total reported value, excl. options
-
$9.92K
-
Value change
-
-$279K
-
Number of sells
-
-11
-
Price
-
$7.54
Significant Holders of Predictive Oncology Inc. - COM (POAI) as of Q3 2025
11 filings reported holding POAI - Predictive Oncology Inc. - COM as of Q3 2025.
Predictive Oncology Inc. - COM (POAI) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 801 shares
.
Largest 10 shareholders include CARNEGIE MELLON UNIVERSITY (691 shares), OSAIC HOLDINGS, INC. (110 shares), VANGUARD GROUP INC (0 shares), WELLS FARGO & COMPANY/MN (0 shares), GEODE CAPITAL MANAGEMENT, LLC (0 shares), STATE STREET CORP (0 shares), RAYMOND JAMES FINANCIAL INC (0 shares), Tower Research Capital LLC (TRC) (0 shares), Virtu Financial LLC (0 shares), and BANK OF AMERICA CORP /DE/ (0 shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.